Guardant Health, Inc.
Company Stats
- Market Cap
- $23.9B
- as of Sep 30, 2026
- Shares Outstanding
- 134.2M
- Free Float
- 69.2%
Income Statement
- Revenue
- $982.0M
- Operating Income
- -$437.2M
- Net Income
- -$416.3M
- EBITDA
- -$397.5M
- Revenue Growth, 3Y
- 29.8%
- FCF Margin, 3Y Avg
- -40.7%
- FCF Margin, Worst Year
- -61.3%
Cash Flow
- Free Cash Flow
- -$233.1M
- FCF Yield
- -1.0%
- Owner FCF Yield
- -1.7%
Balance Sheet
- Cash & Equivalents
- $378.2M
Returns & Capital
- Share Repurchases
- $45.0M
- Buyback Yield, 3Y Avg
- 0.1%
- SBC, 3Y Avg
- $132.5M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $982.0M | -$233.1M | -23.7% |
| FY2024 | $739.0M | -$274.9M | -37.2% |
| FY2023 | $563.9M | -$345.5M | -61.3% |
| FY2022 | $449.5M | -$386.9M | -86.1% |
| FY2021 | $373.7M | -$284.1M | -76.0% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 31, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back